Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 16p11 2p12 2 Microduplication Syndrome C4518821
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 16p11 2p12 2 Microduplication Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
16p11 2p12 2 Microduplication Syndrome C4518821
0-null
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
16p11 2p12 2 Microduplication Syndrome C4518821
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
16p11 2p12 2 Microduplication Syndrome C4518821
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
16p11 2p12 2 Microduplication Syndrome C4518821
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
16p11 2p12 2 Microduplication Syndrome C4518821
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
16p11 2p12 2 Microduplication Syndrome C4518821
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 16p11-2p12-2-microduplication-syndrome-C4518821 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Discriminating power |
|---|---|---|---|
| Acute illness | May cause cortisol deficiency and salt-wasting crisis. | Acute adrenal crisis is not an established feature. | High |
| Development | Growth or puberty may be affected; cognition is not the core feature. | Developmental delay and learning difficulty may occur. | Moderate |
| Physical findings | Ambiguous genitalia may occur in some affected infants. | Distinctive features are reported only in some people. | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Suspected adrenal insufficiency
Hormone imbalance and possible salt-wasting fit the supplied endocrine description.
High
Abnormal adrenal steroid testing
Supports further evaluation for 21-hydroxylase deficiency, without using a cutoff here.
Moderate
Genital ambiguity with endocrine concern
This finding is described for CAH but still requires clinician confirmation.
Moderate
Choose 16p11 2p12 2 Microduplication Syndrome C4518821 when
Confirmed chromosomal duplication
The diagnosis depends on extra material in the 16p11.2-p12.2 region.
High
Developmental concerns without adrenal crisis
Learning and developmental features better match the sparse syndrome description.
Moderate
Need for supportive developmental care
Management is described as supportive rather than hormone replacement.
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | May be abnormal; exact cutoffs are not supplied. | No characteristic adrenal abnormality is established. | An abnormal result suggests endocrine disease but is not itself a complete diagnosis. |
| Serum electrolytes | Salt-wasting may disturb sodium and potassium balance. | No specific electrolyte pattern is established. | Results need urgent clinical correlation and do not prove either condition. |
| Chromosomal microarray | Not the defining test for this enzyme disorder. | May identify the microduplication. | Genetic confirmation should be interpreted by a qualified clinician. |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic condition often managed with lifelong hormone replacement; exact outcomes are not supplied.
- Factors
- Salt-wasting risk, hormone control, growth, and puberty may influence course.
16p11 2p12 2 Microduplication Syndrome C4518821
- Outcome
- Chronic developmental course is possible, but prognosis is not established here.
- Factors
- Degree of developmental delay, learning needs, and associated findings may matter.
Time frame: Both may be lifelong; onset details are not established.
Confirmed diagnosis, severity, associated complications, and access to appropriate care.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | A recognized possible emergency in salt-wasting disease. Not described as characteristic. Emergency symptoms require immediate medical care. |
| Growth and puberty | Growth issues and hormonal effects may occur. Growth effects are not established by the source. Monitoring needs depend on the confirmed diagnosis. |
| Learning needs | Not the central described complication. Learning difficulty or developmental delay may require support. Educational needs should be assessed individually. |
Patient education highlights
- HighEmergency warning signs
For suspected CAH, vomiting, dehydration, or collapse needs urgent care; do not wait for comparison information.
- MediumDifferent causes
One condition concerns adrenal hormone production; the other is a chromosomal copy-number finding.
- MediumIndividual interpretation
Features vary, and sparse source data do not establish prognosis or treatment details.